These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2201750)

  • 21. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting human T cell responses against Bordetella species.
    De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
    J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated immunity after pertussis vaccination and after natural infection.
    Zepp F; Knuf M; Habermehl P; Schmitt HJ; Meyer C; Clemens R; Slaoui M
    Dev Biol Stand; 1997; 89():307-14. PubMed ID: 9272364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
    Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
    J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T cell immunity against Bordetella pertussis analyzed at clonal level.
    De Magistris MT; Rappuoli R; Tagliabue A
    Ann Ist Super Sanita; 1991; 27(1):33-6. PubMed ID: 1683526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein.
    Gray LS; Huber KS; Gray MC; Hewlett EL; Engelhard VH
    J Immunol; 1989 Mar; 142(5):1631-8. PubMed ID: 2521885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.
    Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I
    Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
    Barbieri JT; Armellini D; Molkentin J; Rappuoli R
    Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans.
    Petersen JW; Ibsen PH; Bentzon MW; Capiau C; Heron I
    FEMS Microbiol Immunol; 1991 Oct; 3(5):279-87. PubMed ID: 1797049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
    Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
    Berbers GA; van de Wetering MS; van Gageldonk PG; Schellekens JF; Versteegh FG; Teunis PF
    Vaccine; 2013 Aug; 31(36):3732-8. PubMed ID: 23742995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pertussis toxin triggers rapid second messenger production in human T lymphocytes.
    Rosoff PM; Walker R; Winberry L
    J Immunol; 1987 Oct; 139(7):2419-23. PubMed ID: 2958548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.
    Rappuoli R; Pizza M; Covacci A; Bartoloni A; Nencioni L; Podda A; De Magistris MT
    FEMS Microbiol Immunol; 1992 Oct; 5(4):161-70. PubMed ID: 1384602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of helper T cells by pertussis toxin during in vivo priming to insulin.
    Grenier-Brosette N; Bettetini D; Fehlmann M; Cousin JL
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):73-86. PubMed ID: 1837558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.
    De Magistris MT; Romano M; Bartoloni A; Rappuoli R; Tagliabue A
    J Exp Med; 1989 May; 169(5):1519-32. PubMed ID: 2469760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
    Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.